title: In vitro tumour cell growth inhibition: a comparative study between allosensitized cytotoxic T lymphocytes and lymphokine activated killer cells.
abstract: There is general agreement that several distinct subpopulation of lymphocytes, including major histocompatibility complex (MHC)-restricted T lymphocytes and non-restricted natural killer, or lymphokine-activated killer (LAK), cells are active in lysing neoplastic cells. In this study experiments were designed to compare the inhibitory effects of LAK cells and allosensitized cytotoxic T lymphocytes (CTL) on in vitro growth of an Epstein-Barr virus-transformed B-cell line (BSM) and of a HTLV-I producer T-cell line (MT-2). It was found that allosensitized CTL are more efficient at inducing BSM, or MT-2, cell growth inhibition than LAK cells. These results are consistent with the hypothesis that MHC-restricted T effector cells could mediate higher tumour suppressive effects than non-MHC restricted LAK cells.
authors.affiliation: Institute of Experimental Medicine, II University of Rome, Italy.
authors.forename: M P
authors.initials: MP
authors.lastname: Fuggetta
authors.forename: E
authors.initials: E
authors.lastname: Alvino
authors.forename: R
authors.initials: R
authors.lastname: Pepponi
authors.forename: R
authors.initials: R
authors.lastname: De Filippi
authors.forename: S
authors.initials: S
authors.lastname: Marini
authors.forename: E
authors.initials: E
authors.lastname: Bonmassar
mesh_terms: D001402:B-Lymphocytes / Q000276:immunology; D002455:Cell Division; D003602:Cytotoxicity, Immunologic; D004306:Dose-Response Relationship, Immunologic; D006131:Growth Inhibitors; D006801:Humans; D066298:In Vitro Techniques; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D008213:Lymphocyte Activation; D009374:Neoplasms, Experimental / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D006131:Growth Inhibitors